Xcout Intel
Optimvia, LLC competitors & alternatives
The 12 closest competitors and alternatives to Optimvia, LLC among biotechnology companies — ranked by similarity to what Optimvia, LLC actually does, not by market-cap band.
Subscribe to see Optimvia, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Optimvia, LLC
Optimvia is a biopharmaceutical company that utilizes its proprietary ADEPT discovery platform to engineer enzymes for synthesizing complex therapeutic molecules. The company's primary product is a commercially viable, biosynthetic alternative to animal-derived heparin, aimed at replacing traditional livestock-sourced supplies and developing novel heparin-based pharmaceuticals.
Optimvia, LLC at a glance
Optimvia, LLC is a biotechnology company headquartered in United States. It has raised at least $12.5M across the 4 funding rounds on record. Its most recent funding round raised $75,000 in March 2026. Xcout tracks 10 named people at Optimvia, LLC, including Keith M. Kleeman (Manager and Chief Executive Officer).
Optimvia, LLC leadership
- Keith M. KleemanManager and Chief Executive Officer
- Edmundo MunizDirector
- James E RothmanDirector
- James RothmanDirector
- John BaldoniDirector
- Keith KleemanDirector
4 more named people on record for Optimvia, LLC, with roles, board committees and tenure — see the full roster →
Optimvia, LLC funding rounds
At least $12.5M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $75,000 | — | |
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $2.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Optimvia, LLC competitors
Ranked by semantic similarity — how close each company is to Optimvia, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
CHARM Therapeutics Inc. is a biopharmaceutical company utilizing proprietary technology platforms for drug discovery and therapeutic pipeline development.
Biotech
Operating within the United States, eXoZymes, Inc. is a pioneering synthetic biochemical enterprise. The company's primary innovation is SimplePath, a sophisticated platform engineered to synthesize a diverse spectrum of chemicals. This output encompasses essential pharmaceuticals, alternative fuels, advanced materials, food additives, and entirely new molecular entities. Integral to its design, the SimplePath platform incorporates distinct modules, each housing one or more enzymes that work synergistically to facilitate specific biocatalytic transformations. The firm was established in 2014 and maintains its corporate headquarters in Monrovia, California.
Biotech
OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Similar biotechnology company
Scala Biodesign develops computational protein design technologies to optimize enzymes, antibodies, therapeutic proteins, and antigens for industries such as pharmaceuticals and chemicals.
Biotech
Antheia, Inc. is an advanced biotechnology research and biosynthesis company headquartered in Menlo Park, California, delivering 21st-century pharmaceutical solutions.
Similar biotechnology company
Alteogen is a biotechnology company that researches and develops next-generation bio-betters, biosimilars, and proprietary drug delivery platforms, including long-acting technologies, antibody-drug conjugates (ADCs), and subcutaneous injection conversion technologies. The company serves the global pharmaceutical and healthcare industries by developing advanced biologic drugs and platform solutions.
Biotech
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.
Life Science
Aralez Bio is advancing greener therapeutic development by harnessing enzymes for biocatalysis and pharmaceutical applications. Headquartered in Berkeley, California, the company was recognized with the Excellence in Green Chemistry Award.
Similar biotechnology company
Sculpta Bio is a biotechnology research company headquartered in San Francisco, California, known as the Protein Sculpting Company.
Biotech
Adaptin Bio is a biotechnology company developing a proprietary drug delivery platform designed to enhance the transfer of therapeutics across biological barriers into the brain and other targeted tissues. Its lead technology, the Brain Bispecific T cell Engager (BRiTE) platform, manipulates the human immune system to target diseases in oncology, central nervous system disorders, autoimmune conditions, and cardiovascular markets.
Biotech
Healx is an AI-native pharmaceutical company that uses artificial intelligence and technology to discover and develop new treatments for rare diseases. The company redevelops, combines, and enhances known compounds to build a drug pipeline aimed at delivering effective therapies to patients.
Similar biotechnology company
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Optimvia, LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Optimvia, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →